Clinical Validation of a New Algorithm for Computerized Dosing of Vitamin K Antagonist Therapy

University Of Perugia

Status: Completed

Conditions: Anticoagulated Patients

Study type: Observational

Funder types: Other

Identifiers

NCT01392040

MIV_AI_10_001

Details and patient eligibility

About

The purpose of this study is to determine whether the new algorithm is safety and effective in proposing the dosage and the timing of oral anticoagulant therapy.

Enrollment: 100 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• to take oral anticoagulant therapy for at least 2 years
• to be in stable conditions for at last 3 months

Exclusion criteria

• patients who need to perform surgery
• patients who interrupt therapy

Trial design

100 participants in 1 patient group

Patients in oral anticoagulant therapy

Description:

Patients taking oral anticoagulant therapy